Trade AstraZeneca ^AZN

AstraZeneca (LSE:AZN) Stock In Focus After Sone Ve Win And Mixed Ultomiris Data

Astrazeneca Plc $AZN Shares Sold by Empire Financial Management Company LLC - Markets Daily

7,433 Shares in Astrazeneca Plc $AZN Acquired by Gateway Wealth Partners LLC

Astrazeneca Plc $AZN Shares Sold by Gabelli Funds LLC

Amundi Raises Stock Holdings in Astrazeneca Plc $AZN

Does AstraZeneca (LSE:AZN) Have More Value Than The Market Prices In?

Gateway Wealth Partners LLC Takes $1.47 Million Position in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca CFO: AI Implementation Not Linked to Job Cuts Amid Growth, ETHRWorld

AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales

Judge Dismisses AstraZeneca's Bid To Stop Maine Pharmacy Law

AstraZeneca's (AZN) Sell Rating Reiterated at Deutsche Bank Aktiengesellschaft - Markets Daily

A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati

AstraZeneca's drug pipeine is splitting opinion among City analysts

Astrazeneca (NYSE:AZN) Posts Quarterly Earnings Results, Beats Estimates By $0.13 EPS - Markets Daily

AstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaft - Stock Observer

Astrazeneca Plc $AZN Holdings Lifted by Evelyn Partners Investment Management LLP

Astrazeneca Plc $AZN Shares Purchased by The Manufacturers Life Insurance Company

Citigroup Issues Positive Forecast for AstraZeneca (LON:AZN) Stock Price - Markets Daily

AstraZeneca reports Phase III results for Ultomiris and Sone-Ve

AstraZeneca PLC (LON:AZN) Receives £153.33 Average PT from Analysts - Markets Daily

AstraZeneca's Sone-Ve Improves Survival In Gastric Cancer Trial

How Illumina's Billion Cell Atlas Expansion Could Reshape Eli Lilly's (LLY) Drug Discovery Edge

AstraZeneca (LON:AZN) Stock Price Expected to Rise, Citigroup Analyst Says - Stock Observer

Evelyn Partners Investment Management Europe Ltd Acquires Shares of 21,991 Astrazeneca Plc $AZN - Daily Political

Astrazeneca Plc $AZN Holdings Lifted by Evelyn Partners Investment Management Services Ltd - Daily Political

GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank

Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury

D-FW Business Datebook: Tattoos, indie books and cinema earnings

AstraZeneca Earnings: As Positive News Flow Continues, More Readouts Expected In the Second Half | Morningstar

AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ...

AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth

AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus

Astrazeneca Q2 Earnings Call Highlights

AstraZeneca drug prices evolving in response to Trump policy, executive says

Westport Asset Management Inc. Sells 7,500 Shares of Astrazeneca Plc $AZN - Zolmax

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth - Update | Morningstar

AstraZeneca Q2 2026 earnings beat on cancer drug sales

AstraZeneca profit rises on strong cancer drug sales

Astrazeneca (NYSE:AZN) Releases Earnings Results, Beats Estimates By $0.53 EPS

AstraZeneca quarterly net profit rises 2% on strong cancer drug sales

Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

Market Open: Vodafone raises guidance, AstraZeneca H1 growth

AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View

First Trust Advisors LP Sells 624,072 Shares of Astrazeneca Plc $AZN

AstraZeneca Posts Sales Growth on Oncology Strength | Morningstar

AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat

AstraZeneca's rare disease drug Ultomiris misses main goal in late-stage trial

AstraZeneca's rare disease drug misses main goal in late-stage trial

AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE

AstraZeneca earnings beat forecasts despite slight revenue miss

FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results

AstraZeneca Stock Leads 3 Blue Chips Trading Below Fair Value

AstraZeneca quarterly net profit rises on strong cancer drug sales - Latest News

Astrazeneca (NYSE:AZN) Posts Earnings Results - Daily Political

AstraZeneca News | Markets Insider

FOMC Out Next Week with Interest Rate Decision

AstraZeneca Q2 Earnings Preview: Can Tagrisso, Imfinzi And Farxiga Sustain Momentum?

Waverly Advisors LLC Sells 118,483 Shares of Astrazeneca Plc $AZN

AstraZeneca Stock Leads 3 Cash Flow Picks Trading Below Fair Value

Ionis Pharmaceuticals (IONS) Trial Setback Sparks Scrutiny, Is The 38% Undervaluation Case Still Credible?

Wealth Alliance LLC Has $1.73 Million Stock Holdings in Astrazeneca Plc $AZN

Lido Advisors LLC Cuts Stake in Astrazeneca Plc $AZN

Compound Planning Inc. Sells 24,013 Shares of Astrazeneca Plc $AZN - Markets Daily

Astrazeneca Plc $AZN Shares Sold by Compound Planning Inc.

Lonza Group Ltd (LONN) Gets a Buy from Bernstein

PNC Financial Services Group Inc. Sells 117,223 Shares of Astrazeneca Plc $AZN - Daily Political

Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase

Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

Public Employees Retirement System of Ohio Buys 677,700 Shares of Astrazeneca Plc $AZN

Analysis-AstraZeneca 'magic' faces rare test after trial failure, share slide - AOL

UK Stocks That May Be Trading Below Their Estimated Value

How Eplontersen's Phase 3 Setback And Scrutiny At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

AstraZeneca Stock Looks Undervalued on Cash Flow Alongside Two UK Shares

AstraZeneca immune from Covid-19 vaccine injury lawsuit | Courthouse News Service

Astrazeneca Plc $AZN Shares Sold by Glenview Trust Co - Markets Daily

AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues | Morningstar

Glenview Trust Co Trims Position in Astrazeneca Plc $AZN - Stock Observer

AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm | Morningstar

Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm

Advancing antibody drug conjugates in gastrointestinal cancers

AstraZeneca Stock And 2 Value Picks Trading Below Cash Flow Estimates

Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN

Temasek Holdings Private Ltd Takes $70.89 Million Position in Astrazeneca Plc $AZN - Stock Observer

Astrazeneca Plc $AZN Shares Sold by Saturna Capital Corp - Daily Political

Does Eplontersen's Phase 3 Miss and Dravet Progress Change The Bull Case For Ionis (IONS)?

FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight

AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value

Burling Wealth Partners LLC Buys Shares of 12,554 Astrazeneca Plc $AZN - Markets Daily

Former AstraZeneca and Novo Nordisk executives join ELRIG Scientific Advisory Board

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk